Arrow Dx

Precision Diagnostics Through AI & Nanotechnology

Mission Statement

Our mission is to develop new tools to help researchers and doctors detect chemical and biological entities in the fight against disease.
A person in lab coat and mask working with equipment.

Enhancing detection across a variety of applications

The Problem

Non-alcoholic fatty liver disease (NAFLD) affects 30% of the U.S population. Caused by excessive accumulation of fat in a person’s liver, NAFLD is asymptomatic in its earliest stages and challenging to detect.

Image hover effect image

The Problem

Image hover effect image

The Solution

The Solution

Arrow Dx is  developing highly sensitive detection chips that can be incorporated into portable sensors.

Image hover effect image

The Solution

The Solution

Arrow Dx is  developing highly sensitive detection chips that can be incorporated into portable sensors.

Our Technology

Our proprietary technology allows for an enhanced detection method necessary for the early diagnosis of many diseases such as COVID-19, E.coli, and NAFLD such that an effective treatment can be found thus making it easier for both the patient and physician.

Our technology is the key to unlocking fast, reliable, and flexible diagnostics for a wide variety of applications ranging from early-stage disease detection to environmental pollutant detection to quality control in the wine industry.

Interview of Dr. Sanjiv Chopra

M.B.B.S., M.A.C.P., Harvard Medical School & James Tullis Firm Chief,
Department of Medicine, at Beth Israel Deaconess Medical Center

Scientific Advisory Board

Board of Advisors